Internal Medicine, Pulmonary Disease · Sebring, FL
NPI
1821038852
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
119 US Highway 27 N
Sebring, FL, 33870
Phone (863) 382-0009
Groups this clinician bills Medicare through
Medicare paid, 2024
$375K
5,070 services
Medicare patients, 2024
710
Average age 77
Drug cost, 2024
$4.4M
8,504 prescriptions
Company payments, 2025
$1,200
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepak T Patel was code 99214 (office e&m - established), 1,558 times for 421 patients. In total Deepak T Patel billed 5,070 services in 39 codes, and Medicare paid $375K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,558 | 421 | $91.92 | $143K |
| 99232 Hospital E&M - Subsequent | Facility | 862 | 195 | $61.35 | $53K |
| 99291 Critical Care E&M | Facility | 566 | 143 | $166.97 | $95K |
| 94060 Pulmonary Function Testing | Office | 315 | 158 | $14.56 | $4,587 |
| 94729 Pulmonary Function Testing | Office | 314 | 158 | $21.15 | $6,641 |
| 94726 Pulmonary Function Testing | Office | 313 | 158 | $20.95 | $6,556 |
| 97597 Debridement | Facility | 149 | 36 | $27.73 | $4,132 |
| 94618 Pulmonary Function Testing | Office | 120 | 97 | $25.66 | $3,079 |
| 99214 Office E&M - Established | Facility | 113 | 33 | $75.83 | $8,569 |
| 99204 Office E&M - New | Office | 73 | 73 | $124.58 | $9,094 |
| 99213 Office E&M - Established | Office | 64 | 51 | $63.92 | $4,091 |
| 94640 Treatment - Miscellaneous | Office | 61 | 61 | $5.98 | $365 |
| 99213 Office E&M - Established | Facility | 56 | 25 | $50.42 | $2,824 |
| 31623 Bronchoscopy | Facility | 56 | 49 | $96.63 | $5,411 |
| 95806 Sleep Study | Office | 50 | 26 | $34.38 | $1,719 |
By year: 2022 $651K for 8,709 services; 2023 $468K for 6,686 services; 2024 $375K for 5,070 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepak T Patel prescribed most often to Medicare patients was Montelukast Sodium, with 403 prescriptions and refills. In total Deepak T Patel wrote 8,504 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 403 | 916 | 113 | $3,232 |
| Prednisone Generic | 383 | 571 | 156 | $2,840 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 309 | 395 | 70 | $251K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 239 | 315 | 85 | $9,203 |
| Azithromycin Generic | 168 | 174 | 113 | $1,324 |
| Potassium Chloride Generic | 161 | 276 | 47 | $2,432 |
| Famotidine Generic | 151 | 337 | 40 | $2,331 |
| Furosemide Generic | 150 | 278 | 50 | $578 |
| Ciprofloxacin Hcl Generic | 150 | 150 | 67 | $1,711 |
| Gabapentin Generic | 132 | 210 | 43 | $2,087 |
| Levothyroxine Sodium Generic | 113 | 243 | 27 | $936 |
| Amlodipine Besylate Generic | 113 | 271 | 36 | $651 |
| Fluticasone Propionate Generic | 112 | 162 | 30 | $1,395 |
| Losartan Potassium Generic | 111 | 302 | 35 | $962 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 109 | 139 | 29 | $88K |
Brand drugs: 1,797 claims; generic drugs: 6,695 claims; opioid claims: 273.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepak T Patel $1,200 ($1,200 in general payments such as food, travel and fees) from 21 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $192.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $192 |
| Insmed, Inc. INSM | 7 | $183 |
| Paratek Pharmaceuticals, Inc. | 7 | $164 |
| Verona Pharma, Inc. VRNA | 4 | $101 |
| Merck Sharp & Dohme LLC MRK | 3 | $85.23 |
| Electromed, Inc. ELMD | 4 | $70.8 |
| Grifols USA, LLC | 3 | $53.57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48.16 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $40.01 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $34.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.